Phase I and pharmacokinetic study of oral irinotecan given once daily for 5 days every 3 weeks in combination with capecitabine in patients with solid tumors

O Soepenberg, H Dumez, Jaap Verweij, D Semiond, MJA deJonge, Ferry Eskens, J Steeg, J Selleslach, S Assadourian, GJ Sanderink, A Sparreboom, AT van Oosterom

Research output: Contribution to journalArticleAcademicpeer-review

28 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)889-898
Number of pages10
JournalJournal of Clinical Oncology
Volume23
Issue number4
DOIs
Publication statusPublished - 2005

Research programs

  • EMC MM-03-86-08

Cite this